We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.67B
AUM Growth
+$449M
Cap. Flow
+$100M
Cap. Flow %
1.77%
Top 10 Hldgs %
21.33%
Holding
617
New
29
Increased
183
Reduced
116
Closed
41

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$44.1M
2
ACGL icon
Arch Capital
ACGL
+$36.2M
3
XYL icon
Xylem
XYL
+$35.6M
4
AME icon
Ametek
AME
+$12M
5
GWW icon
W.W. Grainger
GWW
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Healthcare 19.27%
3 Consumer Discretionary 10.8%
4 Industrials 9.16%
5 Financials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNA icon
501
CNA Financial
CNA
$14.2B
$154K ﹤0.01%
4,000
CMRX
502
DELISTED
Chimerix, Inc.
CMRX
$150K ﹤0.01%
121,000
FATE icon
503
Fate Therapeutics
FATE
$286M
$147K ﹤0.01%
30,700
ALLO icon
504
Allogene Therapeutics
ALLO
$649M
$144K ﹤0.01%
31,400
AVXL icon
505
Anavex Life Sciences
AVXL
$255M
$142K ﹤0.01%
18,000
WRB icon
506
W.R. Berkley
WRB
$26.9B
$142K ﹤0.01%
3,600
SU icon
507
Suncor Energy
SU
$79.4B
$141K ﹤0.01%
4,800
DQ
508
Daqo New Energy
DQ
$823M
$123K ﹤0.01%
+3,228
New +$135K
IXJ icon
509
iShares Global Healthcare ETF
IXJ
$4.07B
$123K ﹤0.01%
1,450
CNXT icon
510
VanEck ChiNext Innovators ETF
CNXT
$105M
$122K ﹤0.01%
4,400
EDIT icon
511
Editas Medicine
EDIT
$396M
$122K ﹤0.01%
15,000
RNAM
512
DELISTED
Avidity Biosciences
RNAM
$121K ﹤0.01%
10,900
KURA icon
513
Kura Oncology
KURA
$800M
$113K ﹤0.01%
11,000
ALEC icon
514
Alector
ALEC
$168M
$111K ﹤0.01%
19,000
TWOU
515
DELISTED
2U Inc
TWOU
$105K ﹤0.01%
869
ETSY icon
516
Etsy
ETSY
$7.75B
$102K ﹤0.01%
1,202
-300
-20% -$28.3K
AFG icon
517
American Financial Group
AFG
$11.8B
$94.3K ﹤0.01%
800
ARQT icon
518
Arcutis Biotherapeutics
ARQT
$3.36B
$92.5K ﹤0.01%
11,100
MNST icon
519
Monster Beverage
MNST
$94.3B
$80.4K ﹤0.01%
1,400
FNF icon
520
Fidelity National Financial
FNF
$13.9B
$79.3K ﹤0.01%
2,200
KOD icon
521
Kodiak Sciences
KOD
$2.6B
$76.1K ﹤0.01%
11,300
KZR
522
DELISTED
Kezar Life Sciences
KZR
$73.8K ﹤0.01%
3,100
ABEV icon
523
Ambev
ABEV
$48.1B
$70K ﹤0.01%
22,000
ERAS icon
524
Erasca
ERAS
$6.3B
$66.8K ﹤0.01%
25,000
RL icon
525
Ralph Lauren
RL
$22.6B
$61.6K ﹤0.01%
500

Similar funds

Erste Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Erste Asset Management held 617 positions worth $5.67B, up 8.6% from $5.22B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Erste Asset Management's Q2 2023 filing shows 29 new, 183 increased, 116 reduced and 41 closed positions. Its largest new stake was UiPath: 660,000 shares worth $11M. The largest sale was Evoqua Water Technologies Corp. Common Stock, an estimated $37.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q2 2023 buy was UiPath: 660,000 shares worth $11M.
  • Erste Asset Management added most to AstraZeneca in Q2 2023, an estimated $44.1M increase.
  • Erste Asset Management's biggest Q2 2023 reduction was Progressive, cutting an estimated $31.7M.
  • Erste Asset Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $37.3M.
  • Erste Asset Management's ten largest holdings make up 21% of its $5.67B portfolio in Q2 2023.
  • Erste Asset Management opened 29 new positions and closed 41 in Q2 2023.
  • Erste Asset Management's portfolio value rose 8.6% quarter-over-quarter to $5.67B.

Based on Erste Asset Management's 13F filing for Q2 2023, filed 26 Nov 2024.